Latest Cancer News

Keytruda Approved for Treatment of Stage III Melanoma (02-21-2019)
The U.S. Food and Drug Administration (FDA) has approved Keytruda for the adjuvant treatment of patients with melanoma with involvement of lymph node(s) following complete surgical resection. Adjuvant... Continue Reading

FDA Approves Nivolumab and Ipilimumab Combination for Advanced Kidney Cancer (02-18-2019)
The Food and Drug Administration (FDA) approved the immunotherapy drugs Opdivo and Yervoy in combination as an initial, or first-line, treatment for patients with advanced kidney cancer whose disease has... Continue Reading

Keytruda Plus Inlyta Improves Survival Compared ot Sutent for Treatment of Advanced Kidney Cancer (02-18-2019)
Results from the randomized, phase III KEYNOTE-426 clinical trial show that first-line therapy with a combination of the PD-1 targeted immunotherapy Keytruda (pembrolizumab) and the VEGF-targeted tyrosine... Continue Reading

More Cancer News

Locations

Louisiana Hematology Oncology Associates
Main Office:
4950 Essen Lane, Ste 500
Baton Rouge, LA 70809
Phone: (225) 767-1311
Fax: (225) 767-1335
Louisiana Hematology Oncology Associates
Satellite Offices:
Woman’s Hospital
9000 Airline Hwy.
Suite 290
Baton Rouge, LA 70815
Phone: (225)767-1311
Gonzales
1104 W. Hwy 30
Gonzales, LA 70737
Phone: (225) 215-1547

Zachary
4753 W. Park Dr.
Zachary, LA 70809
Phone: (225) 658-8779